CEACAM16

CEACAM16 is a secreted glycoprotein that builds and maintains the structural and mechanical integrity of the cochlear tectorial membrane, where it functions as an essential matrix-organizing factor for hearing (PMID:25080593, PMID:22544735). It is deposited into the tectorial membrane from interdental and Deiters cells around the onset of hearing (postnatal days 12–15) and physically interacts with both α-tectorin (TECTA) and β-tectorin (TECTB); its loss reduces TECTB levels, abolishes the striated-sheet matrix, and eliminates Hensen's stripe, indicating that CEACAM16 stabilizes the TECTA–TECTB matrix (PMID:25080593, PMID:22544735). CEACAM16 forms oligomers through unpaired cysteines and mediates homotypic trans-interactions via its C-terminal N2 immunoglobulin variable-like domain, providing a molecular basis for its matrix-crosslinking role (PMID:22544735). Functionally, CEACAM16 is required to maintain tectorial membrane stiffness and viscosity in adult animals and to balance cochlear amplifier gain against instability, as its loss produces aberrant spontaneous otoacoustic emissions and progressive, apically-biased age-related degradation of the tectorial membrane core (PMID:31249509, PMID:34555361, PMID:25080593). Recessive loss-of-function splice variants cause progressive deafness, while a dominant missense allele (p.G169R) impairs secretion of the protein, directly linking CEACAM16 dysfunction to hereditary hearing loss (PMID:25589040, PMID:29703829).

1. 2012 Medium

   Established the molecular basis for how CEACAM16 could organize an extracellular matrix by showing it self-associates, defining oligomerization and trans-interaction as its core biochemical activities.

   Evidence Ectopic N2-domain cell-surface expression with homotypic cell-sorting assay and reducing vs. non-reducing Western blots

   PMID:22544735

   Open questions at the time

   • Structural basis of N2-domain trans-interaction not resolved
   • Which cysteines mediate oligomerization not mapped
   • Stoichiometry of oligomers undefined
2. 2012 Medium

   Defined the spatial and temporal context of CEACAM16 function, showing it is secreted into the tectorial membrane at hearing onset and that its loss alters membrane morphology.

   Evidence Immunohistochemistry of cochlear sections from wild-type and Ceacam16-null mice across postnatal ages

   PMID:22544735

   Open questions at the time

   • Mechanism coupling secretion timing to hearing onset unknown
   • Single-lab localization data
3. 2014 High

   Resolved how CEACAM16 contributes to matrix architecture by identifying TECTA and TECTB as binding partners and linking its loss to collapse of the striated-sheet matrix and Hensen's stripe.

   Evidence Ceacam16-null mouse with IHC and EM of tectorial membrane plus Co-IP/interaction assays for TECTA and TECTB

   PMID:25080593

   Open questions at the time

   • Binding interfaces with TECTA/TECTB not mapped
   • Whether interactions are direct or matrix-mediated not fully distinguished
   • Stoichiometry within the striated sheet unknown
4. 2014 High

   Connected CEACAM16-dependent matrix structure to cochlear amplifier function, showing its loss causes aberrant spontaneous otoacoustic emissions correlated with loss of Hensen's stripe.

   Evidence In vivo SOAE, SFOAE, TEOAE, and ABR measurements in Ceacam16-null vs. wild-type mice

   PMID:25080593

   Open questions at the time

   • Quantitative link between matrix mechanics and amplifier gain not established
   • Frequency-dependence mechanism unresolved
5. 2015 Medium

   Provided a disease-relevant mechanism by showing the p.G169R missense mutation reduces secretion efficiency, explaining how a dominant allele impairs CEACAM16 deposition.

   Evidence Immunofluorescence, Western blot, and conditioned-medium secretion assay in transfected HEK293T cells comparing wild-type and mutant

   PMID:25589040

   Open questions at the time

   • Cellular fate of retained mutant protein not determined
   • In vivo consequence in cochlea not tested
   • Single-lab heterologous system
6. 2018 Medium

   Established that biallelic loss of CEACAM16 function is sufficient to cause deafness, defining a recessive loss-of-function disease mechanism distinct from the dominant secretion-defect allele.

   Evidence Minigene splicing assays for two splice-altering variants, OtoSCOPE NGS, and Sanger segregation

   PMID:29703829

   Open questions at the time

   • Residual protein levels in patients not quantified
   • Genotype–phenotype severity correlation limited
   • Single-lab functional validation
7. 2019 Medium

   Demonstrated that CEACAM16 maintains tectorial membrane integrity over the lifespan, with its loss accelerating apically-biased matrix degradation and producing progressive late-onset hearing loss.

   Evidence Longitudinal ABR, DPOAE, SOAE, and histology in null mice at 1, 6, and 12 months

   PMID:31249509

   Open questions at the time

   • Molecular cause of apical-to-basal gradient unknown
   • Whether degradation is degradative vs. failure-to-maintain not distinguished
8. 2021 Medium

   Directly quantified the mechanical role of CEACAM16, showing it is required to maintain adult tectorial membrane stiffness and viscosity while being dispensable for juvenile mechanics.

   Evidence Direct biophysical stiffness and viscosity measurements of isolated tectorial membranes from null and wild-type mice at juvenile and adult ages

   PMID:34555361

   Open questions at the time

   • Molecular basis for age-dependent mechanical decline unresolved
   • Link between measured mechanics and amplifier gain not directly tested
   • Single-lab measurement

• How CEACAM16 oligomerization and trans-interaction are structurally coordinated with TECTA/TECTB binding to assemble the striated-sheet matrix, and how this assembly sets frequency-dependent mechanical properties, remains unresolved.
• No structural model of the CEACAM16–tectorin complex
• Binding interfaces unmapped
• Mechanism linking matrix architecture to amplifier gain undefined